Overview
This study is a pragmatic, randomized controlled pilot trial comparing remimazolam with propofol for endoscopic procedures, designed to assess the feasibility and clinical outcomes associated with implementing a pragmatic randomized trial of sedation practices in the endoscopy setting.
Eligibility
Inclusion Criteria:
- Aged 18 years of age or older
- Planned endoscopic procedure
- American Society of Anesthesiologists (ASA) Physical Status I to III
Exclusion Criteria:
- Planned tracheal intubation
- Procedure length anticipated to exceed 45 minutes
- Previously participated in the trial
- Pregnant (defined as a positive test using pre-procedural clinical testing performed as part of their routine care) or breastfeeding
- Allergy or hypersensitivity to one of the study medications
- Blind, deaf, or unable to communicate in English
- Co-enrollment in other interventional studies that, in the opinion of the site investigator and/or their delegate, might interfere with study participation, collection, or interpretation of the study data


